SOD1 and amyotrophic lateral sclerosis: In this study, we determined the total SOD activity in the tear fluid and blood serum of ALS patients and FUS (1–359) transgenic mice and demonstrated that alterations in SOD activity are present in both the patient cohort and the ALS animal model.